SCL Science Inc. (KOSDAQ:246960)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,050.00
+200.00 (2.26%)
Last updated: Jun 11, 2025

SCL Science Statistics

Total Valuation

SCL Science has a market cap or net worth of KRW 84.96 billion. The enterprise value is 96.88 billion.

Market Cap 84.96B
Enterprise Value 96.88B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

SCL Science has 8.48 million shares outstanding. The number of shares has increased by 9.04% in one year.

Current Share Class 8.48M
Shares Outstanding 8.48M
Shares Change (YoY) +9.04%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 5.32%
Owned by Institutions (%) n/a
Float 4.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.47
PB Ratio 3.21
P/TBV Ratio 5.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -20.48
EV / Sales 16.50
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -11.95

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.88.

Current Ratio 2.40
Quick Ratio 2.06
Debt / Equity 0.88
Debt / EBITDA n/a
Debt / FCF -2.86
Interest Coverage -10.04

Financial Efficiency

Return on equity (ROE) is -21.11% and return on invested capital (ROIC) is -7.35%.

Return on Equity (ROE) -21.11%
Return on Assets (ROA) -6.39%
Return on Invested Capital (ROIC) -7.35%
Return on Capital Employed (ROCE) -9.34%
Revenue Per Employee 94.69M
Profits Per Employee -76.29M
Employee Count 62
Asset Turnover 0.13
Inventory Turnover 5.81

Taxes

In the past 12 months, SCL Science has paid 681,990 in taxes.

Income Tax 681,990
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -8.95% in the last 52 weeks. The beta is 0.45, so SCL Science's price volatility has been lower than the market average.

Beta (5Y) 0.45
52-Week Price Change -8.95%
50-Day Moving Average 8,177.40
200-Day Moving Average 8,672.60
Relative Strength Index (RSI) 84.50
Average Volume (20 Days) 132,069

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SCL Science had revenue of KRW 5.87 billion and -4.73 billion in losses. Loss per share was -650.65.

Revenue 5.87B
Gross Profit 1.51B
Operating Income -4.47B
Pretax Income -4.73B
Net Income -4.73B
EBITDA -3.19B
EBIT -4.47B
Loss Per Share -650.65
Full Income Statement

Balance Sheet

The company has 11.37 billion in cash and 23.21 billion in debt, giving a net cash position of -11.84 billion or -1,396.66 per share.

Cash & Cash Equivalents 11.37B
Total Debt 23.21B
Net Cash -11.84B
Net Cash Per Share -1,396.66
Equity (Book Value) 26.50B
Book Value Per Share 3,115.92
Working Capital 13.65B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.79 billion and capital expenditures -320.08 million, giving a free cash flow of -8.11 billion.

Operating Cash Flow -7.79B
Capital Expenditures -320.08M
Free Cash Flow -8.11B
FCF Per Share -956.19
Full Cash Flow Statement

Margins

Gross margin is 25.77%, with operating and profit margins of -76.07% and -80.56%.

Gross Margin 25.77%
Operating Margin -76.07%
Pretax Margin -80.55%
Profit Margin -80.56%
EBITDA Margin -54.29%
EBIT Margin -76.07%
FCF Margin n/a

Dividends & Yields

SCL Science does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.04%
Shareholder Yield n/a
Earnings Yield -5.57%
FCF Yield -9.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SCL Science has an Altman Z-Score of 0.4 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.4
Piotroski F-Score 1